Skip to content
Glycotest
  • Home
  • About us
    • Leadership and Shareholders
  • Technology
    • The HCC Panel
    • Intellectual Property
  • Clinical Data
  • News
    • News and Updates
    • Media
    • Video
  • Contact

Glycotest’s HCC Panel test for early-stage liver cancer receives additional patent protection in Japan, Singapore, Australia, the Philippines, Hong Kong and China.

October 4, 2026February 13, 2026 by Glycotest
Categories Uncategorized
Glycotest CEO Charles Swindell to present at Life Science Pennsylvania’s largest partnering event of the year—Life Sciences Future 2025 conference on September 25-26.
Glycotest secures US$3.22 million to advance liver cancer diagnostic platform

Speak with the team

Get in touch

Give us a call

+1 484-431-3483

Send us a message

info@glycotest.com

© 2026 | Glycotest | All Rights Reserved